Octodrine

Octodrine
Clinical data
Other names	DMHA; Ottodrina; Vaporpac; Amidrine; 2-Aminoisoheptane; 2-Amino-6-methylheptane; 1,5-Dimethylhexylamine; 6-Methyl-2-heptylamine; 6-Methyl-2-heptanamine
Routes of; administration	Oral, inhaled
ATC code	none;
Legal status
Legal status	US: Unapproved "New Drug" (as defined by 21 U.S. Code § 321(p)(1)). Use in dietary supplements, food, or medicine is unlawful; otherwise uncontrolled.;
Identifiers
	IUPAC name 6-methylheptan-2-amine;
CAS Number	543-82-8 ;
PubChem CID	10982;
ChemSpider	10517;
UNII	3GQ9E911BI;
CompTox Dashboard (EPA)	DTXSID8046535 ;
ECHA InfoCard	100.008.047
Chemical and physical data
Formula	C8H19N
Molar mass	129.247 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)CCCC(C)N;
	InChI InChI=1S/C8H19N/c1-7(2)5-4-6-8(3)9/h7-8H,4-6,9H2,1-3H3; Key:QNIVIMYXGGFTAK-UHFFFAOYSA-N;
	(verify)

Octodrine (also known as Vaporpac or DMHA) is a stimulant drug whose pharmacology was studied in a dozen animal studies from the 1940s through the 1970s. These studies found that octodrine can increase blood pressure and cardiac output in animals. The drug was previously approved for use by the FDA as an inhalant (i.e., Vaporpac and Tickle Tackle Inhaler) and in Germany as an oral agent as part of a multicomponent medication (i.e., Ambredin and Ordinal), but is no longer available.

DMHA has also been found as an adulterant in sports supplements and is sold online as a designer drug.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.